Circulating Th17 cell proportion and the ability to produce IL-17, the representative Th17 cytokine, are both enhanced in active BD, and Th17 levels decrease during the remission stage versus the active stage [70, 71]. This evidence concerns the gene IL17A and Behcet disease.